CDC: COVID Vax Not Linked to Sudden Deaths in Young Adults
(MedPage Today) -- The hunt for a signal of excess sudden cardiac deaths among young people after COVID-19 vaccination left Oregon health officials empty-handed, they reported.
Investigators searched death certificates for Oregon residents 16... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 11, 2024 Category: Cardiology Source Type: news
Global Stockpile of Cholera Vaccine Is Gone as Outbreaks Spread
One company is going to great lengths to build it up, but it will be years before it returns to the minimum level. (Source: NYT Health)
Source: NYT Health - April 11, 2024 Category: Consumer Health News Authors: Stephanie Nolen Tags: Vaccination and Immunization Drugs (Pharmaceuticals) Disasters and Emergencies Cholera Gavi, the Vaccine Alliance World Health Organization Bharat Biotech Ltd EuBiologics Co your-feed-healthcare your-feed-science Source Type: news
COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023
This report describes COVID-19 vaccination coverage in the World Health Organization African Region during 2021-2023. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 11, 2024 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Vaccination COVID-19 Source Type: news
Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022
This report describes a review of Oregon death certificate data to assess whether young people in Oregon might be dying after receiving a COVID-19 vaccine. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 11, 2024 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report COVID-19 Source Type: news
Measles - United States, January 1, 2020-March 28, 2024
This report describes measles cases in the United States during 2020-2024 (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 11, 2024 Category: American Health Tags: Measles Measles Vaccination MMWR Morbidity & Mortality Weekly Report Source Type: news
Long Covid trials aim to clear lingering virus —and help patients in need
One Monday morning last September, Shelley Hayden pulled into a parking spot in an underground garage at the University of California San Francisco (UCSF). She switched off the ignition, pushed the red record button on her cellphone, and gazed into the camera. “The time has come,” said Hayden, long dark-blond hair framing her blue eyes. “Here we are, I’m actually getting to do something.”
More than 3 years earlier, in the summer of 2020, Hayden had come down with COVID-19 while visiting family in Colorado. Since then she’s been plagued by the disease’s cruel sequel, Long Covid, whose symptoms include ov...
Source: ScienceNOW - April 11, 2024 Category: Science Source Type: news
Moderna puts plans for African vaccine plant on hold
Pledges to invest in pandemic preparedness with facility in Kenya fall short as sales of Covid jabs decline (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 11, 2024 Category: Pharmaceuticals Source Type: news
Whooping Cough Is Surging in China With Tens of Thousands of Cases and Over a Dozen Deaths
Discussions are needed to determine if the country should update the vaccine it uses for the disease or adjust the immunization program, Shen Hongbing, director of the Chinese Center for Disease Control and Prevention, said at a conference in March.
“It requires close attention to prevent and control the spread of whooping cough in China,” Shen said, according to local media reports.
Vaccination woes
Whooping cough infections have been rising in China since 2014, with more than 30,000 in 2019, according to the Chinese CDC. After a respite during the Covid isolation days, they bounced ...
Source: TIME: Health - April 11, 2024 Category: Consumer Health News Authors: Bloomberg News Tags: Uncategorized News Desk overnight wire Source Type: news
Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry
Founded in 2011, Elicio Therapeutics Inc. ELTX has made several significant strides in the last 13 years. The immunotherapy company has completed multiple successful preclinical trials and has been featured in publications like Nature Medicine and Cancer Immunology Research, a journal of the…#eliciotherapeutics #amp #eli002 #kras #cpg #grandviewresearch #trialinprogress #amplify7p #eli0027p #pdac (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2024 Category: Consumer Health News Source Type: news
Apnea Tied to Non-Invasive Ventilation in Hospitalized COVID Patients
(MedPage Today) -- In hospitalized veterans with COVID-19, obstructive sleep apnea (OSA) was associated with greater use of non-invasive ventilation (NIV), but booster vaccination reduced this risk, a retrospective study found.
While univariate... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - April 10, 2024 Category: Infectious Diseases Source Type: news
AACR: Novel Personalized Vaccine Feasible for Head and Neck Cancer
TUESDAY, April 9, 2024 -- The novel viral-based personalized cancer vaccine, TG4050, which encodes up to 30 patient- and tumor-specific sequences is feasible and safe for patients with resected head and neck squamous cell carcinoma, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2024 Category: Pharmaceuticals Source Type: news
Moderna ’s (NASDAQ:MRNA) Latest Cancer Treatment Gives Shares New Life
For a while, things weren’t looking all that great for biotech stock Moderna (NASDAQ:MRNA). Its primary stock in trade, the COVID-19 vaccine, has b... (Source: Reuters: Health)
Source: Reuters: Health - April 9, 2024 Category: Consumer Health News Source Type: news
Pfizer RSV Shot Meets Goals in Trial Of High-risk Adults Under Age 60 Pfizer RSV Shot Meets Goals in Trial Of High-risk Adults Under Age 60
Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 9, 2024 Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news
Young Adults May Soon Be Able to Get an RSV Shot
Pfizer Inc.’s RSV shot produced immune reactions in young adults at higher risk of severe illness just as well as in older people, spurring the company’s plans to apply for wider U.S. approval.
A single dose of the vaccine, called Abrysvo, produced a strong immune response in adults ages 18 to 59 with conditions such as asthma, diabetes, or chronic lung disease, Pfizer said. Based on the final-stage trial results, the company plans to ask the Food and Drug Administration to extend the shot’s approval to adults 18 and older.
[time-brightcove not-tgx=”true”]
RSV, or respiratory syncytial ...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Madison Muller and Robert Langreth/Bloomberg Tags: Uncategorized healthscienceclimate wire Source Type: news
Adding Vaccine to Immunotherapy for Liver Cancer Shows Promise in Early Trial
TUESDAY, April 9, 2024 -- A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.The vaccine could help liver cancer patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 9, 2024 Category: General Medicine Source Type: news
